Related Experiment Video

Updated: Jun 1, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Treatment of human cancers by NO-releasing reagents related to Mn-SOD

H Takeshita1, K Isobe, S Akiyama

  • 1NATL INST LONGEV SCI,OBU,AICHI 474,JAPAN. NAGOYA UNIV,SCH MED,DEPT SURG 2,SHOWA KU,NAGOYA,AICHI 466,JAPAN. NAGOYA UNIV,SCH MED,DEPT IMMUNOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN.

Oncology Reports
|May 19, 2011
PubMed

Insights

Nitric oxide (NO) can fight tumors, but some cancers resist it. This study found that resistant cancer cells increase manganese-superoxide dismutase (Mn-SOD) to protect against NO radicals, offering insights for NO-based cancer drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Nitric oxide (NO) exhibits anti-tumor properties.
  • The precise mechanisms by which NO affects human cancer cells remain incompletely understood.
  • Investigating cellular responses to NO is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To elucidate the relationship between nitric oxide (NO) and superoxide dismutases (SODs) in cancer cells.
  • To understand how cancer cells respond to NO exposure.
  • To explore the potential of NO donors as anti-cancer agents.

Main Methods:

  • Utilized S-nitroso-N-acetyl penicillamine (SNAP), a nitric oxide (NO)-releasing reagent.
  • Treated various human cancer cell lines with SNAP.
  • Assessed the expression of manganese-superoxide dismutase (Mn-SOD) mRNA and Mn-SOD enzymatic activity.

Main Results:

  • Enhanced expression of manganese-superoxide dismutase (Mn-SOD) mRNA was observed in cancer cells treated with SNAP.
  • Increased enzymatic activity of Mn-SOD was detected in response to SNAP treatment.
  • These findings indicate a protective mechanism employed by some cancer cells against NO.

Conclusions:

  • Human cancer cells resistant to nitric oxide (NO) may upregulate manganese-superoxide dismutase (Mn-SOD) expression as a defense mechanism.
  • This enhanced Mn-SOD activity helps protect cancer cells from NO-induced damage.
  • Understanding this resistance pathway provides a potential strategy for utilizing NO donors in cancer therapy.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...